Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Cipla
Baxter
US Army
Chubb
Queensland Health
Chinese Patent Office
Express Scripts
McKesson
Deloitte

Generated: August 16, 2017

DrugPatentWatch Database Preview

ARISTOSPAN Drug Profile

« Back to Dashboard

What is the patent landscape for Aristospan, and when can generic versions of Aristospan launch?

Aristospan is a drug marketed by Sandoz Inc and is included in one NDA.

The generic ingredient in ARISTOSPAN is triamcinolone hexacetonide. There are fifty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the triamcinolone hexacetonide profile page.

Summary for Tradename: ARISTOSPAN

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list13
Clinical Trials: see list1
Patent Applications: see list1,828
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ARISTOSPAN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc
ARISTOSPAN
triamcinolone hexacetonide
INJECTABLE;INJECTION016466-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Sandoz Inc
ARISTOSPAN
triamcinolone hexacetonide
INJECTABLE;INJECTION016466-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Cerilliant
Daiichi Sankyo
Moodys
Federal Trade Commission
Deloitte
QuintilesIMS
Accenture
Cantor Fitzgerald
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot